Zobrazeno 1 - 10
of 1 009
pro vyhledávání: '"Toda, A"'
Autor:
Naohiro Toda, Eri Muso, Toshiyuki Komiya, Takaki Sakurai, Hisako Hirashima, Satoshi Kurahashi, Katsuhiro Io, Jun Takeoka, Masaaki Fujita, Katsuya Tanigaki
Publikováno v:
Internal Medicine. 61:1027-1032
Rosai-Dorfman-Destombes disease (RDD) is a non-Langerhans cell histiocytosis characterized by the accumulation of histiocytes inside the lymph nodes or extranodally. The association between RDD and IgG4-related disease (IgG4-RD) is discussed. We here
Autor:
Takeo Sato, Masaya Toda, Hideaki Hanaki, Toshiaki Komatsu, Takatoshi Nakamura, Yoko Takayama, Yoshinori Tomoda, Hirotsugu Okamoto, Koichiro Atsuda, Hirohisa Miura
Publikováno v:
Surgery. 171:1000-1005
Background During surgery, the effectiveness of perioperative prophylactic antibiotic administration against surgical site infections is inferred from serum concentrations and not from tissues where local infections occur. This study aimed to measure
Autor:
Tae Hatsuyama, Takaki Toda, Azusa Wakamoto, Yuji Mukai, Hideki Sato, Tatsunari Yoshida, Akihisa Fujita, Nobuo Inotsume
Publikováno v:
Therapeutic Drug Monitoring. 43:772-779
Background Routine therapeutic drug monitoring is a promising approach for the rational use of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) and anaplastic lymphoma kinase (ALK) inhibitors. The purpose of this study was to d
Autor:
Masahiko Miura, Hiroshi Watanabe, Ryoichi Yoshimura, Takahiro Asakage, Hiroyuki Harada, Kazuma Toda, Atsushi Kaida
Publikováno v:
Anticancer Research. 41:6259-6266
Background/aim To evaluate the outcomes of induction chemotherapy and/or external beam radiotherapy (EBRT) followed by brachytherapy (BT) in patients with tongue cancer who had a waiting period for BT or a large tumor that was not suitable for BT. Pa
Autor:
Kazuhiko Sekine, Ayumi Yoshifuji, Masataro G. Toda, Kentaro Fujii, Munekazu Ryuzaki, Takahide Kikuchi, Kazuto Itoh, Yasushi Kondo
Publikováno v:
Clinical and Experimental Nephrology
Background Critical coronavirus disease 2019 (COVID-19) has a high fatality rate, especially in hemodialysis (HD) patients, with this poor prognosis being caused by systemic hyperinflammation; cytokine storms. Steroid pulse therapy or tocilizumab (TC
Publikováno v:
Journal of Alzheimer's Disease
Background: Memantine, an NMDA receptor antagonist, is used for the treatment of Alzheimer’s disease. There is a caution to refrain from administrating memantine in combination with some specific drugs such as amantadine or dextromethorphan due to
Autor:
Fumihiko Ogata, Takehiro Nakamura, Megumu Toda, Masashi Otani, Naohito Kawasaki, Noriaki Nagai, Shouko Iijima
Publikováno v:
Chemical and Pharmaceutical Bulletin. 69:789-795
In this study, the effect of contact time, temperature, pH, and coexistences on the adsorption of phosphate ions using the complex nickel-aluminum-zirconium hydroxide (NAZ) was evaluated. Moreover, the recovery of adsorbed phosphate ions from NAZ usi
Publikováno v:
Journal of Nuclear Cardiology. 29:2325-2335
The activation of the renin-angiotensin-aldosterone system prevents the uptake of norepinephrine and promotes structural remodeling of the heart. The mineralocorticoid receptor antagonist (MRA) eplerenone prevents left ventricular (LV) remodeling in
Autor:
Kojiro Taura, Etsuro Hatano, Rei Toda, Hiroto Nishino, Motohiko Satoh, Satoru Seo, Keiko Iwaisako, Yosuke Kasai, Kenji Yoshino, Masayuki Okuno
Publikováno v:
Anticancer Research. 41:1803-1810
Background/aim Sinusoidal obstruction syndrome (SOS) after neoadjuvant chemotherapy with oxaliplatin for colorectal liver metastases (CRLM) has been reported to lead to early recurrence. This study investigated the effects of SOS on the development o
Autor:
Hirotomo Nakashima, Shin-Ichiro Kawaguchi, Shin-ichiro Fujiwara, Iekuni Oh, Yumiko Toda, Hirofumi Nakano, Takashi Nagayama, Ken Ohmine, Kento Umino, Sae Matsuoka, Takashi Ikeda, Rui Murahashi, Ryoko Yamasaki, Yoshinobu Kanda, Chihiro Yamamoto, Masahiro Ashizawa, Kazuya Sato, Shoko Ito, Tetsuaki Ban, Daisuke Minakata, Kaoru Hatano
Publikováno v:
International Journal of Hematology. 114:79-84
High-dose methotrexate (MTX) is widely used for the treatment of hematological malignancies. Despite the application of routine supportive care measures, such as intensive fluid hydration and urine alkalinization, nephrotoxicity is still a problem. T